XML 30 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net loss $ (7,814) $ (6,496) $ (2,614)
Adjustments required to reconcile net loss to net cash used in operating activities      
Depreciation 68 23 11
Accrued interest on convertible securities 20
Accrued interest on deposits (45)
Share based compensation expenses 241 790 299
Unrealized gain loss from foreign currency derivative activities (68)
Changes in operating assets and liabilities items:      
Decrease (increase) in accounts receivable 8 (8)
Decrease (increase) in inventories (1,026) 5 9
Decrease (increase) in governmental grants receivables (54) 8 (11)
Increase in other receivables and prepaid expenses (136) (496) (30)
Increase (decrease) in advance payments (41) 79 63
Increase (decrease) in deferred revenues (12) (12) 9
Increase in accounts payable 254 84 40
Increase in accrued payroll and other employment related accruals 163 194 119
Decrease in advance payments on governmental grant (42)
Increase in accrued expenses 36 99 32
Net cash used in operating activities (8,434) (5,714) (2,103)
CASH FLOWS FROM INVESTING ACTIVITIES:      
Purchase of property and equipment (194) (48) (36)
Investment in deposits, net (4,054)
Prepayments of leasing (18)
Net cash used in investing activities (4,248) (66) (36)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from issuance of shares issued in the public offering, net of issuance cost 1,670
Proceeds from issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses 14,319
Proceeds from issuance of ordinary shares and warrants, net of issuance cost 2,925
Proceeds from issuance of SAFEs 500
Refund to SAFE investors (100)
Proceeds from credit line 800
Repayment of credit line (800)
Proceeds from issuance of ordinary shares as a result of exercise of warrants 1,449 160
Exercise of options 1
Payment on behalf of issued shares 12
Net cash provided by financing activities 3,119 14,879 2,938
Net increase (decrease) in cash and cash equivalents (9,563) 9,099 799
Cash and Cash Equivalents at the beginning of year 10,373 1,274 475
Cash and cash equivalents at the end of year 810 10,373 1,274
Supplemental Disclosure:      
Interest on credit line 40
Interest received from deposits (305)
Conversion of SAFEs to equity 400
Right-of-use asset recognized against lease liability $ 644 $ 229